New ovarian cancer treatment is developed
Tuesday, September 16, 2008 - 14:07
in Health & Medicine
IRVINE, Calif., Sept. 16 (UPI) -- A U.S. scientist says a combination of the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit for relapsed ovarian cancer.